DOI: https://doi.org/10.21203/rs.3.rs-701380/v1
Aspergillus flavus (A. flavus) is an important fungus that produces aflatoxins, of which aflatoxin B1 (AFB1) is the most toxic and prone to contaminating food. This leads to economic losses in agricultural products and human health risks. Sterigmatocystin (STC) is a precursor in the metabolic biosynthesis of AFB1. In this study growth of A. flavus was not affected by the presence of STC, but AFB1 production was inhibited at certain concentrations. To uncover the mechanism, transcriptomic profiles of A. flavus in the presence or absence of STC were evaluated in PDB. A total of 3377 differentially-expressed genes were identified; 1182 were up-regulated and 2195 were down-regulated. GO function and KEGG pathway enrichment analysis indicated that these genes were mainly involved in the organization and biosynthesis of cellular components, organelle part, organelle division, macromolecular compound functions; the main pathway was valine, leucine and isoleucine synthesis and aflatoxin synthesis. The clustered genes responsible for AFB1 biosynthesis were down-regulated to different degrees; norB expression was completely suppressed in the experimental group. This study provides new insights into control of A. flavus and the mechanisms regulating mycotoxin production.
Aflatoxin B1 (AFB1) is one of the most important mycotoxins in the world due to its frequent detection at high concentrations as a contaminant in human food and animal feed1–3. AFB1 is a polyketide compound synthesized by secondary metabolic pathways in Aspergillus. AFB1 can cause pathophysiological changes in some organisms (e.g. reduced growth rate, disturbed gastrointestinal tract, silenced immune responses and malnutrition); while also inducing a variety of histopathological manifestations in hepatocytes (e.g. proliferation of the bile duct and fatty degeneration of the hepatocytes)4–7. AFB1 is known to induce hepatocellular carcinoma in various animals including rodents, poultry, non-human primates and fishes8–9. For these reasons, AFB1 is classified by the International Agency for Research on Cancer (IARC) as a group 1 compound10.
Another important mycotoxin is sterigmatocystin (STC) which is produced mainly by A. nidulans and A. versicolor, but also some other species belonging to the genera Aschersonia, Botryotrichum, Emericella and Chaetomium11–12. STC is a potential carcinogen, mutagen and teratogen and was categorized by IARC as a group 2 compound [13]. Interestingly, STC shares its biosynthetic pathway with AFB1, and the relative concentrations of AFB1 and STC in contaminated foods depends on the invasive species. Aspergillus versicolor and A. nidulans are not able to metabolize STC into O-methylsterigmatocystin, which is the the direct precursor of AFB1. As a result, food and feed infested by these fungi often contain high concentrations of STC. In contrast, in food and feed invaded by A. flavus and A. parasiticus, which are able to metabolize STC, concentrations of STC are generally low14–16,11.
The simultaneous occurrence of multiple mycotoxins in an individual product is a common phenomenon, and co-occurence of AFB1 and STC has been reported in food commodities (De Saeger, personal communication, 2012)17–20. Exposure to multiple mycotoxins may lead to synergistic, additive or antagonistic toxic effects and the toxicity of mycotoxin combinations cannot always be predicted based on their individual toxicities21–24. Mycotoxins with similar modes of action would generally be expected to have the least additive effects25. The mechanisms of AFB1 toxicity is through DNA modification, metabolic activation, cell death/transformation and cell deregulation26–29. In contrast, the toxicity of STC is through DNA adducts, inhibition of the cell cycle and mitosis, increases in ROS formation and lipid peroxidation30–33. Thus, there are similarities and differences in the mode of action of AFB1 and STC.
Methods to remove mycotoxins from contaminated food, or degrade them into less toxic or non-toxic compounds are required. Many methods for degradation of AFB1 have been reported, including adsorption, physical and chemical reduction34–37. In addition, AFB1 is degraded by microorganisms including bacteria, yeasts and moulds; this has been studied extensively in recent years38–42.
To our knowledge, there is no information in the literature about interactions between the presence of STC in foods and AFB1 production. In the present work the effect of STC on A. flavus growth and AFB1 biosynthesis were studied in potato dextrose broth (PDB).
The effect of STC, at five concentrations (0.02, 0.1, 2.0, 10.0, 50.0 µg/mL), on mycelial growth of A. flavus and AFB1 production in PDB medium over 11 days are shown in Table 1. The dry weight of mycelia increasing with increasing time in culture. In the control A. flavus grew well in PDB medium with sustained growth over the 11 days. When STC was added to the medium, mycelial dry weights at the highest concentration of STC were significantly different to the control and the other treatments (p>0.05) after 3 and 4 days growth (except for 10.0 µg/mL in 3 days); From the 5th day, there was no significant difference in A. flavus dry weights amongst any of the STC concentrations and the control except in the 10 µg/mL treatment (p<0.05). This indicates that A. flavus growth was not affected by the presence of STC, even at high concentrations.
Table 1
Effect of different sterigmatocystin concentrations on dry weight of mycelium
Added concentration(µg/mL) |
mycelial weights(mg) |
|||||
3d |
4d |
5d |
7d |
9d |
11d |
|
CK |
25.32±1.92a |
26.97±3.42b |
42.62±4.22bc |
53.49±6.28b |
60.27±3.77ab |
75.81±8.16a |
0.02 |
27.75±1.64a |
33.63±2.87a |
46.29±2.23bc |
55.94±6.86ab |
56.05±2.51b |
78.91±3.57a |
0.1 |
28.75±2.08a |
35.30±2.33a |
40.63±3.06c |
61.21±4.13ab |
65.83±6.40a |
77.36±3.69a |
2.0 |
20.10±2.31b |
19.76±2.47c |
44.59±3.95bc |
61.18±1.57ab |
69.29±1.70a |
80.91±5.78a |
10 |
16.54±2.58b |
20.76±1.34c |
54.90±4.29a |
60.85±2.74ab |
63.73±2.44ab |
71.51±7.84a |
50 |
18.55±0.64b |
18.98±1.51c |
50.32±1.20ab |
65.84±2.20b |
68.82±4.66a |
77.48±4.13a |
AFB1 production increased with increasing culture time in all treatments and the control, however the rate varied (Table 2). The relative ability to produce toxin did not show a linear trend in relation to STC concentration. For example, after 3 days AFB1 production was 17.18 µg/L, 0.38 µg/L, 2.94 µg/L and 33.36 µg/L at STC concentrations of 0.02 mg/L, 0.1 mg/L, 2 mg/L and 10 mg/L, respectively, while in the control it was 61.62 µg/L. Maximum AFB1 production reached 545.70 µg/L, 95.65 µg/L, 366.71 µg/L and 804.90 µg/L in the same four STC concentrations, and 1145.67 µg/L in the control. Hence, a certain concentration of STC inhibited AFB1 production, and at an STC concentration of 0.1 µg/mL AFB1 production was significantly different than the control (p>0.05). It is noteworthy that at an STC concentration of 50 mg/L AFB1 production was not significantly different to the control (p<0.05) between days 4 and 7 of growth.
Table 2
Effect of different sterigmatocystin concentrations on aflatoxin B1 production of Aspergillus flavus
Added concentration(µg/mL) |
AFB1 production(µg/L) |
|||||
3d |
4d |
5d |
7d |
9d |
11d |
|
CK |
61.62±8.52a |
255.79±9.98a |
372.35±89.93a |
759.72±61.02a |
1199.85±203.76a |
1145.67±71.44a |
0.02 |
17.18±1.22c |
108.06±22.45b |
203.17±69.28b |
419.09±32.51b |
414.90±42.27c |
545.70±155.63bc |
0.1 |
0.38±0.10d |
27.23±2.64c |
39.00±3.97c |
77.02±11.11d |
66.68±10.18d |
95.65±46.30d |
2.0 |
2.94±0.79d |
22.57±8.65c |
81.27±27.23c |
233.39±73.04c |
365.99±82.04c |
366.71±60.23c |
10 |
33.36±6.12b |
140.09±13.21b |
310.18±19.74ab |
674.41±52.34a |
783.96±120.74b |
804.90±131.15b |
50 |
69.29±9.91a |
131.09±22.47b |
308.93±29.37ab |
479.80±56.80b |
966.24±138.27ab |
1264.37±189.36a |
Transcriptome sequencing of the six samples (two groups, three duplicates) of A. flavus CGMCC 3.2980 generated a total of 30.31 million raw reads; amongst the total read pairs, 29.38 million passed purity filtering standards. Through base composition and mass analysis, it was apparent that there were few low quality bases. This met the quality control standard of sequencing and requirements for subsequent bioinformatic analysis.
Comparative analysis of the genome of A. flavus was done using clean reads after filtering with TopHat 2.0 software. The results showed that over 85% of reads were uniquely mapped to the A. flavus genome and multiple mapped reads or fragments coincided with the standard of half-point ratio below 10% in multiple localization-sequencing. This meant that the reference genome was appropriate and three was no pollution in the experiment.
Gene expression level is reflected in transcription abundance; the lower the transcription abundance, the lower the level of gene expression. The overall transcriptional activity of genes in our data were quantified by calculating the number of reads per kilobase of exon per million mapped reads (FPKM); it is generally recognized that an FPKM>1 means that the gene is expressed. Gene expression levels are shown in Table 3.
Table 3
Proportion of genes at different expression levels
Samples |
FPKM Interval |
||||
0~1 |
1~3 |
3~15 |
15~60 |
>60 |
|
CK_1 |
233 |
399 |
1041 |
833 |
872 |
CK_2 |
220 |
407 |
1032 |
818 |
853 |
CK_4 |
251 |
423 |
1048 |
829 |
788 |
TJ_1 |
697 |
489 |
722 |
637 |
614 |
TJ_2 |
754 |
463 |
728 |
655 |
587 |
TJ_4 |
594 |
473 |
753 |
673 |
684 |
To identify differences in molecular responses (based on read count) between experimental groups and the control group, we identified 3377 differentially transcribed (FDR<0.05, ∣log2 FC∣≥1) genes, of which 1182 genes (35.00%) were up-regulated and 2195 (65.00%) genes were down-regulated.
Functional assignments were defined by Gene Ontology (GO) terms (http://www.genontology.org), which provided a broad functional classification of genes and gene products for various biological processes (BP), cellular components (CC) and molecular functions (MF). GO functional enrichment analysis revealed that: 13 MF terms were enriched, mainly involved with oxidoreductase activity, catalytic activity, structural constituent of ribosome and monooxygenase activity; 18 CC terms were enriched including intracellular organelle part, intracellular part, cell part and macromolecular complexes; 65 BP terms were enriched including cellular component organization or biogenesis, oxidation-reduction processes, single-organism metabolic processes, single-organism processes and cellular protein metabolic processes (Table 4).
Table 4
GO functional enrichment analysis of differentially expressed genes
GO ID |
Number |
Pop number |
P value_uncorrected |
FDR |
Description |
MF |
|||||
GO:0016491 |
548 |
1573 |
4.81297E-10 |
0 |
Oxidoreductase activity |
GO:0003824 |
1480 |
5098 |
6.51185E-10 |
0 |
catalytic activity oxidoreductase activity, acting on paired donors, |
GO:0016705 |
119 |
287 |
9.20882E-09 |
0 |
with incorporation or reduction of molecular oxygen |
GO:0003735 |
6 |
113 |
1.43745E-08 |
0 |
structural constituent of ribosome |
GO:0004497 |
119 |
291 |
1.88615E-08 |
0 |
monooxygenase activity |
BP |
|||||
GO:0071840 |
53 |
413 |
2.58209E-10 |
0 |
cellular component organization or biogenesis |
GO:0055114 |
543 |
1538 |
4.10448E-10 |
0 |
oxidation-reduction process |
GO:0044710 |
918 |
2926 |
5.87454E-10 |
0 |
single-organism metabolic process |
GO:0044699 |
1217 |
4145 |
6.47599E-10 |
0 |
single-organism process |
GO:0044267 |
76 |
504 |
1.37828E-09 |
0 |
cellular protein metabolic process |
CC |
|||||
GO:0044446 |
98 |
667 |
3.2679E-10 |
0 |
intracellular organelle part |
GO:0044422 |
98 |
672 |
3.71546E-10 |
0 |
organelle part |
GO:0032991 |
168 |
996 |
4.08468E-10 |
0 |
macromolecular complex |
GO:0044424 |
456 |
2232 |
5.59664E-10 |
0 |
intracellular part |
GO:0044464 |
538 |
2507 |
9.22963E-10 |
0 |
cell part |
Note: FDR: P value_correctedNote: FDR: P value_corrected |
To further investigate the biological functions and interactions amongst genes, pathway-based analysis was done using the Kyoto Encyclopedia of Genes and Genomes (KEGG, http://www. genome.ad.jp/kegg) pathway database. Results showed that 3377 DEGs were involved in 110 pathways. The top ten down- and up-regulated genes enriched in KEGG is shown in Table 5. For down-regulated genes, the most enriched were involved in aflatoxin biosynthesis, followed by starch and sucrose metabolism and tyrosine metabolism; this explains why gene expression involved in aflatoxins synthesis and glucose metabolic pathway was suppressed in the experiment group. For up-regulated genes, valine, leucine and isoleucine biosynthesis was the most enriched, followed by alanine, aspartate and glutamate metabolism; this accounts for why genes participating in amino acid metabolism in the experimental groups were highly expressed. KEGG metabolic pathway analysis showed that enrichment of valine, leucine and isoleucine biosynthesis and aflatoxin biosynthesis was significant at p≤0.05.
Table 5
Top 10 KEGG enrichments for down- and up-regulated genes
Ko id |
Term |
Number |
P value_uncorrected |
|
Genes down -egulated |
|
|
map00254 |
Aflatoxin biosynthesis |
13 |
0.0000 |
map00500 |
Starch and sucrose metabolism |
20 |
0.0011 |
map00350 |
Tyrosine metabolism |
18 |
0.0012 |
map00650 |
Butanoate metabolism |
12 |
0.0018 |
map00380 |
Tryptophan metabolism |
15 |
0.0024 |
map00071 |
Fatty acid degradation |
12 |
0.0058 |
map02010 |
ABC transporters |
5 |
0.0066 |
map04213 |
Longevity regulating pathway - multiple species |
8 |
0.0070 |
map00591 |
Linoleic acid metabolism |
3 |
0.0114 |
map00061 |
Fatty acid biosynthesis |
7 |
0.0125 |
|
Genes up-regulated |
|
|
map00290 |
Valine, leucine and isoleucine biosynthesis |
14 |
0.0000 |
map00250 |
Alanine, aspartate and glutamate metabolism |
16 |
0.0002 |
map04113 |
Meiosis - yeast |
18 |
0.0003 |
map00770 |
Pantothenate and CoA biosynthesis |
11 |
0.0003 |
map00970 |
Aminoacyl-tRNA biosynthesis |
15 |
0.0004 |
map00670 |
One carbon pool by folate |
8 |
0.0007 |
map00300 |
Lysine biosynthesis |
8 |
0.0011 |
map03008 |
Ribosome biogenesis in eukaryotes |
18 |
0.0015 |
map00230 |
Purine metabolism |
23 |
0.0020 |
map00260 |
Glycine, serine and threonine metabolism |
18 |
0.0036 |
To investigate the effect of STC on secondary metabolism synthesis of A. flavus, we used CIFR (Center for Integrated Fungal Research) information (http://weir.statgen.ncsu.edu/aspergillus/chromosomes.php) and SMURF (http://www.jcvi.org/smurf) software to analyze 55 secondary metabolic gene clusters from A. flavus. Expression of most gene clusters was not affected by STC. Comparative analysis of secondary metabolism gene expression demonstrated that in 639 secondary metabolism genes there were 162 genes with significantly different expression (q-value≤0.001), of which 17 were backbone genes: AFLA_004450, AFLA_010020, AFLA_064560, AFLA_069330 and AFLA_139490 encoded mainly non-ribosomal peptide synthetase (NRPS); AFLA_006170, AFLA_10545, AFLA_128060, AFLA_137870 and AFLA_139410 are responsible for polyketide synthase, PKS; AFLA_017840, AFLA_023020, AFLA_079400, AFLA_105190 encode NRPS-like synthase and AFLA_028660, AFLA_066890 and AFLA_139480 encode for mitochondrial translation initiation factor IF-2, cytochrome P450 and hybrid PKS/NRPS enzymes, respectively.
Most secondary metabolic gene clusters were down-regulated, with only the minority being up-regulated. In the 2# gene cluster, backbone gene AFLA_004450, which is responsible for encoding dimethylallyl transferase, was up-regulated, but AFLA_004370 and AFLA_004400 were down-regulated. In the 11# gene cluster, only AFLA_028660 was up-regulated while there was no significant difference in expression of other genes in this cluster. Similarly, the genes AFLA_082220, AFLA_082230 and AFLA_082250 in the 27# gene cluster and AFLA_101690 and AFLA_101710 in the 33# gene cluster were all up-regulated to varying degrees. Amongst the up-regulated genes, AFLA_112890 and AFLA_066740 encode major facilitator superfamily transporters (MFS), which have an important role in transfer of some metabolites. Furthermore, genes involved in amino acid synthesis were differentially expressed to varying degrees; for example, AFLA_005510, AFLA_041550, AFLA_083270 and AFLA_126970, which encode amino acid permease, cysteine β-lyase, GABA permease and arginine permease, respectively, were up-regulated, but AFLA_038620 (encoding branched amino acid transferase) and AFLA_062910 (encoding specific proline permease) were down-regulated.
AFB1 synthesis genes were located on the 54# gene cluster. In this study, 30 genes were all down-regulated to varying degrees; norB was completely repressed in the experimental group (Table 6). However, there was no difference in expression of the global regulatory genes of secondary metabolite, laeA and veA,. Also, brlA, which is involved with growth was down-regulated.
Table 6
Analysis of genes expressed in the biosynthesis of aflatoxins
Gene name |
RPKM |
Log2 |
q value |
DGE |
Annotated gene function |
|||
CK |
TJ |
TJ/CK |
||||||
AFLA_139200 |
152.1003 |
0.0890 |
-10.7389 |
1.076E-83 |
down |
aflQ/ ordA/ ord-1/ oxidoreductase / cytochrome P450 monooxigenase |
||
AFLA_139210 |
917.6813 |
0.2213 |
-12.0176 |
7.73E-142 |
down |
aflP/ omtA/ omt-1/ O-methyltransferase A |
||
AFLA_139220 |
2925.1377 |
0.5760 |
-12.3101 |
5.21E-174 |
down |
aflO/ omtB/ dmtA/ O-methyltransferase B |
||
AFLA_139230 |
99.5160 |
0.1137 |
-9.7740 |
1.589E-45 |
down |
aflI/ avfA/ cytochrome P450 monooxygenase |
||
AFLA_139240 |
1044.9193 |
0.2383 |
-12.0981 |
2.354E-65 |
down |
aflLa/ hypB/ hypothetical protein |
||
AFLA_139250 |
799.4160 |
0.1230 |
-12.6661 |
2.64E-125 |
down |
aflL/ verB/ desaturase/ P450 monooxygenase |
||
AFLA_139260 |
786.0533 |
0.1383 |
-12.4723 |
3.22E-117 |
down |
aflG/ avnA/ ord-1/ cytochrome P450 monooxygenase |
||
AFLA_139270 |
1428.8010 |
1.4530 |
-9.9416 |
5.055E-67 |
down |
aflNa/ hypD/ hypothetical protein |
||
AFLA_139280 |
227.1293 |
0.0113 |
-14.2907 |
5.76E-61 |
down |
aflN/ verA/ monooxygenase |
||
AFLA_139290 |
821.2367 |
0.1913 |
-12.0675 |
7.899E-43 |
down |
aflMa/ hypE/ hypothetical protein |
||
AFLA_139300 |
6524.7297 |
1.3467 |
-12.2423 |
1.72E-134 |
down |
aflM/ ver-1/ dehydrogenase/ ketoreductase |
||
AFLA_139310 |
1071.7900 |
0.2320 |
-12.1736 |
3.66E-130 |
down |
aflE/ norA/ aad/ adh-2/ NOR reductase/ dehydrogenase |
||
AFLA_139320 |
1900.3200 |
0.4837 |
-11.9399 |
2.15E-124 |
down |
aflJ/ estA/ esterase |
||
AFLA_139330 |
3153.5033 |
1.8543 |
-10.7318 |
7.72E-131 |
down |
aflH/ adhA/ short chain alcohol dehydrogenase |
||
AFLA_139340 |
560.8290 |
3.6423 |
-7.2666 |
3.33E-124 |
down |
aflS/ pathway regulator |
||
AFLA_139360 |
92.4453 |
4.6113 |
-4.3253 |
5.357E-37 |
down |
aflR / apa-2 / afl-2 / transcription activator |
||
AFLA_139370 |
143.3517 |
3.2357 |
-5.4694 |
2.01E-161 |
down |
aflB / fas-1 / fatty acid synthase beta subunit |
||
AFLA_139380 |
117.8963 |
5.8397 |
-4.3355 |
3.961E-70 |
down |
aflA / fas-2 / hexA / fatty acid synthase alpha subunit |
||
AFLA_139390 |
2307.8407 |
5.6377 |
-8.6772 |
1.382E-74 |
down |
aflD / nor-1 / reductase |
||
AFLA_139400 |
2940.4380 |
1.0157 |
-11.4994 |
1.607E-86 |
down |
aflCa / hypC / hypothetical protein |
||
AFLA_139410 |
196.8083 |
4.3753 |
-5.4913 |
4.01E-164 |
down |
aflC / pksA / pksL1 / polyketide synthase |
||
AFLA_139420 |
333.8647 |
4.3997 |
-6.2457 |
1.04E-112 |
down |
aflT / aflT / transmembrane protein |
||
AFLA_139430 |
178.0950 |
0.3763 |
-8.8864 |
1.018E-60 |
down |
aflU / cypA / P450 monooxygenase |
||
AFLA_139440 |
25.7907 |
0.0000 |
_ |
1.613E-06 |
down |
aflF / norB / dehydrogenase |
||
AFLA_139450 |
11.8450 |
0.0000 |
_ |
3.169E-06 |
down |
conserved hypothetical protein |
||
AFLA_139460 |
558.1760 |
1.0897 |
-9.0007 |
1.47E-48 |
down |
MFS multidrug transporter, putative |
||
AFLA_139470 |
320.0510 |
1.5767 |
-7.6653 |
1.088E-14 |
down |
FAD dependent oxidoreductase, putative |
||
AFLA_139480 |
493.3330 |
3.8730 |
-6.9930 |
2.24E-48 |
down |
dimethylallyl tryptophan synthase, putative |
||
AFLA_139490 |
8.2883 |
0.0330 |
-7.9725 |
3.695E-43 |
down |
hybrid PKS/NRPS enzyme, putative |
||
AFLA_139500 |
0.8250 |
0.0257 |
-5.0064 |
3.439E-05 |
down |
conserved hypothetical protein |
Much research has been devoting to controlling the occurrence of aflatoxins. Some natural substances with inhibitory effects have been found e.g. onions, garlic extract, eugenol, khellin, caffeine, piperlongumine, luteolin, saccharol, resveratrol and tannic acid43, but these are all exogenous substances. This study found that particular concentrations of STC can inhibit the synthesis of AFB1, while not affecting fungal growth. Transcriptome analysis showed that 30 genes in the AFB1 biosynthetic gene cluster were down-regulated to varying degrees. Meanwhile, KEGG analysis showed that most DEGs were enriched in branched-chain amino acids (BCAAs).
Aspergillus flavus reproduces asexually depending on conidia production for growth and development, which is precisely controlled by multiple genes. The genes wetA, brlA and abaA are the main regulatory proteins involved in the sporulation process and play important roles in the different stages of conidia production. Activation of the brlA gene is a key step in conidia production by Aspergillus44; knockout of brlA makes Aspergillus isolates form quill-like structures with slender stems that cannot produce conidia, while over-expression interrupts isolate growth45. Generally, aflatoxin synthesis is always associated with slow growth46. In our study, brlA gene expression was down-regulated meaning that growth of A. flavus remained active, leading to the synthesis of AFB1. However, there was no significant difference in expression of the other two genes, wetA and abaA; in combination with results of the phenotypic study, we speculate that STC cannot affect the growth of A. flavus. Lin et al (2013) found that 5-azacytidine induced up-regulation of brlA, which blocked sporulation, resulted in a fluffy phenotype, and influenced AFB1 synthesis47.
Secondary metabolic pathways in fungi are relatively complex, involving polyketone synthase, epoxide hydrolase, methyl transferase, reductase, dehydrogenase, cytochrome P450 monooxygenase and fatty acid synthase. However, one type of enzyme can be produced as a result of more than one gene, and it is difficult to determine whether a gene is involved in secondary metabolism. Using metabolic analysis tools and SMURF software, Georgianna et al., (2010) found 55 secondary metabolic pathways in A. flavus, including 27 NRPS, 22 PKS, ciproanilic acid synthesis, spore pigment synthesis and aflatoxin synthesis metabolic pathways that perform specific biological functions48–49. AflR is a transcriptional regulatory gene for aflatoxin synthesis and is responsible for activation of almost all structural genes. As the transcription factor auxiliary gene, AflS cooperates with aflR to prevent inhibition and guarantee aflatoxin synthesis. LaeA and veA are global regulatory factors involved in regulation of aflatoxin synthesis and were down-regulated in our study.
Aflatoxins are highly oxidative metabolic products and oxidative stress is a necessary condition for their formation50. Transcriptome analysis demonstrated that Cu–Zn superoxide dismutase expression was raised, which is consistent with previous research43. Thirty genes involved in aflatoxin synthesis, were all down-regulated demonstrating that STC directly inhibits the genes encoding enzyme in this gene cluster which inhibits aflatoxin production. Some antioxidant enzymes encoded by gene updated in the presence of STC can also inhibit synthesis of aflatoxins.
The role of amino acid metabolism in aflatoxin synthesis is complex. Some amino acids can be used as carbon or nitrogen sources in growth and aflatoxin synthesis. In A. flavus, phenylalanine, tyrosine, tryptophan, proline and arginine can be used in this way for aflatoxin synthesis51. Arginine is necessary for aflatoxin synthesis in A. parasiticus, and can replace aspartate and alanine52–53. KEGG enrichment analysis found that, in 67 metabolic pathways, BCAAs metabolic activity was associated with biosynthesis of aflatoxins, and other basic ammonia acids and acidic amino acid metabolism mainly related to the fungal growth. Eighteen ribosome biosynthesis genes were up-regulated showing that STC may promote the growth of A. flavus to a certain extent, but inhibited the synthesis of AFs. This result is consistent with previous studies54.
STC is a precursor of aflatoxin synthesis and, theoretically, an increase in STC should enhance the ability of isolates to synthesize aflatoxins. However, cell metabolism and microbial secondary metabolism are sophisticated processes. Although precursor substances can inhibit metabolic production, this has not been reported before for aflatoxin synthesis; there is a large body of research on synthesis of antibiotics for example. In general, exogenous precursor added during synthesis of antibiotics can control synthetic direction and increase antibiotics production. Epothilone is a type of polyketide secondary metabolite, and when precursors are added they have an inhibitory effect on epothilone synthesis55. Similarly, FK506 output is significantly improved during fermentation in the presence of precursors, but only at low concentrations56. Aflatoxin synthesis in A. flavus CGMCC declined in the presence of STC this study. However, under the same conditions, aflatoxin production by other isolates increased. This confirms that aflatoxin synthesis is isolate specific, and can vary depending on the nutrient medium, external environment and the degree of tolerance to particular substances57.
Synthesis of secondary metabolites is closely related to primary metabolism because cell energy, precursors and co-factors can potentially limit secondary metabolism. Many enzymes involved in aflatoxin biosynthesis and catalytic reactions are NADPH dependent. Glucose may control aflatoxin biosynthesis by NADPH generated carbon metabolism repression and the tricarboxylic acid cycle. Therefore, NADPH/NADP+ levels in cells may also affect aflatoxin synthesis58–59. Lipid metabolism is also closely associated with aflatoxin synthesis. NADPH/NADP determines whether acetyl-CoA enters fatty metabolism or aflatoxin anabolism. It is possible that a high proportion of NADPH/NADP enables acetyl-CoA to enter fatty metabolic pathways, while low levels encourage its entry into other pathways60. The pentose phosphate pathway is the main source of intracellular NADPH in organisms, some important gene expressed significant difference may be the other possible influencing factors in aflatoxin synthesis.
In order to discuss the influence of STC on secondary metabolite synthesis in A. flavus, we used transcriptome sequencing analysis to identify 3377 differentially expressed genes of which 1182 genes were up-regulated and 2195 genes were down-regulated. GO function and KEGG pathway enrichment analysis indicated these genes mainly participated in cellular component organization and biosynthesis of components, organelle part, organelle division, macromolecular compound functions, and the main pathway was valine, leucine and isoleucine synthesis and aflatoxin synthesis. We also showed that STC had least influence on 55 secondary metabolic gene cluster, but that 30 genes on the aflatoxin synthesis gene cluster were expressed to varying degrees; norB was completely suppressed in the experimental group, suggesting that STC probably increases oxidoreduction enzyme activity, facilitating growth of isolates, and improving branched chain amino acid biosynthesis, thus inhibiting synthesis of aflatoxins.
Equipment used in this study included: an autoclave MLS-3750 (Labo, Janpa); drying oven DHG-9070A (DHG, China); centrifuge 5804R (Eppendorf, Germany); clean Bench KLC (KLC, China); vortex mixer vx200 (Labnet, USA); incubator (Boxun, China); ultrasonic instrument (Kunshan, China); and optical microscope Nikon E100 (Nikon, Japan). Water was ultra-purified in a MilliQ@ system (Millipore, USA) for use throughout the study.
AFB1 and STC standards were obtainted from Sigma (St. Louis, MO, USA). The C18 column was purchased from Agilent (California, USA). All reagents used were purchased from Sigma and were of analytical grade. HPLC solvents were of HPLC grade. The potato dextrose agar (PDA) and potato dextrose broth (PDB) were from Huankai (Guangzhou, China).
The aflatoxigenic isolate, A. flavus (CGMCC 3.2980) was purchased from China General Microbiological Culture Collection Center. This isolate was maintained on PDA slants at 4℃ until activated. Inoculum was prepared by culturing A. flavus on PDA for 7 days at 30℃; conidia were harvested aseptically and suspended homogeneously in sterile distilled water containing 0.05% Tween 80. Conidial concentration was determined using a haemocytometer and adjusted to 1×107 conidia ml-1 before use in experiments.
Each replicate flask containing 100 mL PDB medium was inoculated with 1 mL of conidial suspension (see section 2.3) and different quantities of STC (0.02, 0.1, 2.0, 10, 50 µg/mL); there were three replicate flasks for each STC concentration and the control. Control flasks contained only conidia of A. flavus and no STC. The flasks were incubated at 30℃ in darkness. On days 3, 4, 5, 7, 9, 11 after inoculation a set of 18 tubes were autoclaved (121℃, 30 min) for safety reasons and mycelial growth and AFB1 concentration of each flask measured.
Fungal dry weights of A. flavus in each treatment and at each sampling time were determined by filtering out the mycelium from each flask using Whatman No 4 filter paper, washing in sterilized water, and then freeze-drying for 24 h at 65℃ before weighing.
The filtrate from each flask was used for AFB1 analysis. Quantification of AFB1 was done following the method described by Guo et al., with some modification61. For extraction of AFB1 from media, 2 mL filtrate was transferred by pipette to a centrifuge tube before centrifugation at 11000 rpm for 10 min. Then 1.5 mL of the supernatant and 4.5 mL acetonitrile aqueous solution containing 1% formic acid were placed in a 10 mL centrifuge tube, vortexed for 1 min and then dried with nitrogen. To each centrifuge tube, 0.1 mg PSA and 1.5 mL acetonitrile aqueous solution (3:7, v:v) containing 0.1% formic acid were added to achieve a constant volume; the mixture was vortexed for 1 min and then subjected to ultrasound in an ultrasonic generator for 5 min prior to centrifugation at 10000 rpm for 5 min. Then 1 mL of the supernatant was filtered through a 0.22 µm nylon filter before analysis using HPLC-MS/MS.
The LCMS-8050 system was a UFLC connected to a triple quadrupole MS analyzer with an electrospray ionization (ESI) interface (Shimadzu, Japan). The separation was run using a ShimadzuShim-pack XR-ODS Ⅲ (75mm×2.0 mm×1.6 µm) column maintained at 40℃ with a flow rate of 300 µL/min. The mobile phases were (A) 0.1% aqueous formic acid solution and (B) MeCN. The elution gradient started with 30% B (0 - 3 min), 50% B - 80% B for 5 min, and finally 30% B for 7 min, isocratic for 1 min. The injection volume was 1 µL.
Total RNA was extracted from cultivated PDB media containing 10 µg/mL STC using TRIzol® reagent according to the manufacturer’s instructions (Invitrogen) and genomic DNA was removed using DNase I (TaKara). Then RNA quality was determined using a 2100 Bioanalyser (Agilent) and quantified using the ND-2000 (NanoDrop Technologies).
An RNA-seq transcriptome library was prepared using the TruSeqTM RNA sample preparation kit from Illumina (San Diego, CA) with 5 μg of total RNA. Messenger RNA was isolated according to the polyA selection method using oligo (dT) beads and then fragmented by fragmentation buffer firstly. Secondly double-stranded cDNA was synthesized using a SuperScript double-stranded cDNA synthesis kit (Invitrogen, CA) with random hexamer primers (Illumina). The synthesized cDNA was subjected to end-repair, phosphorylation and ‘A’ base addition according to Illumina’s library construction protocol. Libraries were size selected for cDNA target fragments of 200–300 bp on 2% Low Range Ultra Agarose followed by PCR amplification using Phusion DNA polymerase (NEB) and 15 PCR cycles. After quantification using TBS380, the paired-end RNA-seq sequencing library was sequenced using the Illumina HiSeq xten (2 × 150bp read length).
The raw paired-end reads were trimmed and quality controlled by SeqPrep (https://github.com/jstjohn/SeqPrep) and Sickle (https://github.com/najoshi/sickle) with default parameters. Clean reads were separately aligned to reference genomes using the orientation mode of TopHat (http://tophat.cbcb.umd.edu/version 2.0.0) software62.The mapping criteria of bowtie were as follows: sequencing reads should be uniquely matched to the genome allowing up to two mismatches, without insertions or deletions. The regions of genes were expanded following depths of sites and the operon obtained. In addition, the whole genome was split into multiple 15 kbp windows that shared 5 kbp. Newly transcribed regions were defined as having more than two consecutive windows without overlapped regions of the gene, where at least two reads mapped per window in the same orientation.
To identify DEGs (differentially-expressed genes) amongst paired samples, the expression level of each transcript was calculated according to the fragments per kilobase of exon per million mapped reads (FRKM) method. RSEM (http://deweylab.biostat.wisc.edu/rsem/) was used to quantify gene abundances63. The R statistical package software EdgeR (Empirical analysis of Digital Gene Expression in R [http://www.bioconductor.org/packages/2.12/bioc/html/edgeR.html]) was used for differential expression analysis64. In addition, functional enrichment analysis including GO and KEGG were done to identify which DEGs and metabolic pathways were significantly enriched in GO terms compared with the whole-transcriptome background (using the Bonferroni-corrected P-value ≤0.05 to determine significance). GO functional enrichment and KEGG pathway analysis were achieved using Goatools (https://github.com/tanghaibao/Goatools) and KOBAS (http://kobas.cbi.pku.edu.cn/home.do)65.
All data generated or analysed during this study are included in this article.
This work was funded by the President Funding of Guangdong Academy of Agricultural Sciences (202008).
Yarong Zhao conceived and designed the experiments; Peirong Chen performend the experiments; Rui Zeng analyzed the data. All authors discussed, edited and approved the final manuscript.
The authors declare no competing interests.